Opthea locks in $239m for eye disease drug trials
MELBOURNE: Opthea has landed one of the biggest biotech raisings of the year, securing $US170m
MELBOURNE: Opthea has landed one of the biggest biotech raisings of the year, securing $US170m
FEATURED
New apartments are helping transform the treatment experience
Plan unveiled to replace former care home with 24 modern retirement flats
Modernist architecture now set to meet affordable housing for seniors
Land carve-ups help build better housing future for remote communities
Best retirement housing design for Global Awards shortlisted
Boomers high-rise set to come with a health hub
INNOVATION
